STUDY DESIGN: We used the California Birth Cohort Database for live births maintained by the California Office of State Health Planning and Development. Our sample included singleton deliveries between 20-44 weeks gestation among non-Hispanic "Black", "Hispanic" White, and non-Hispanic "White" women. Risk groups were classified using ICD-9 codes for previous PTB, any hypertension, preeclampsia, any diabetes, infection, mental illness, smoking, and drug or alcohol dependence. We used logistic regression to compare odds of PTB in Black and Hispanic compared to White women among women who had none of these risk factors and among women with each risk factor. All models were adjusted for other risk factors and for maternal age, interpregnancy interval, education, obesity, and poverty status. RESULTS: 2,320,020 women were included in this analysis (7% Black, 61% Hispanic, and 32% White). PTB rates were higher among Black (9.9%) and Hispanic (6.9%) women compared to White women (6.0%, adjusted odds ratio [aOR] ¼ 1.5 and aOR ¼ 1.3, respectively). While PTB rates across risk groups differed dramatically (wherein the highest rates were among Black and Hispanic women with preeclampsia (33.0% and 29.5%, respectively)) or previous PTB (30.5% and 29.6%, respectively)), the magnitude of the disparities remained consistent for Black and Hispanic women compared to White women across most risk factor groupings (aORs 1.4 to 1.6 for Black versus White women and 1.2 to 1.3 for Hispanic versus White women). Exceptions included women who had a previous PTB (aOR of 1.1 for Black versus White women), any hypertension (aOR 1.5 for Hispanic versus White women), or smoked (aOR 1.1 for Hispanic versus White women). CONCLUSION: While all risk factors were associated with an increased risk of PTB across race/ethnicity groupings, these racial/ethnic disparities remained fairly similar suggesting that others factors (e.g., stress, racism) are driving disparities.
691 Outcomes of elective induction of labor at 38 weeks versus expectant management until week 39
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Oregon Health & Science University, Portland, OR OBJECTIVE: Recent evidence suggests that elective induction of labor may reduce cesarean deliveries and other obstetric outcomes. This study analyzes differences in maternal and neonatal outcomes from elective induction of labor (eIOL) at 38 weeks versus one additional week of expectant management in nulliparous women at community hospitals. STUDY DESIGN: We conducted a retrospective cohort study of singleton, vertex, nonanomalous deliveries in community hospitals in California between 2007 and 2011 using linked hospital discharge and vital statistics data (n¼231,567). We compared outcomes from eIOL, defined by the Joint Commission, at 38 weeks against one Poster Session IV additional week of expectant management and delivery at 39 weeks. Maternal outcomes of interest were cesarean delivery, operative vaginal delivery, perineal tear, chorioamnionitis, and endomyometritis. Neonatal outcomes of interest were intrauterine fetal death, 5 minute Apgar less than 7, NICU admission, respiratory distress syndrome (RDS), hypoglycemia, hypoxic ischemic encephalopathy (HIE) and jaundice. Results were compared using chi square analysis and examined using multivariate logistic regression. A p-value of less than 0.05 was used to indicate statistical significance. RESULTS: In our cohort of 231,567 deliveries, there were significant differences in the incidence of cesarean delivery, perineal tears, chorioamnionitis, and endomyometritis in women who were electively induced at 38 weeks compared to those who received expectant management and delivered at 39 weeks. However, the rate of operative vaginal delivery was not significantly different between the two groups. The rate of intrauterine fetal death was also significantly decreased when women were electively induced at 38 weeks. Logistic regression analysis indicated expectant management for one additional week, with delivery at 39 weeks, significantly increased cesarean deliveries (OR 1.45, 95% CI 1.37-1.54) but decreased RDS in neonates (OR 0.83, 95% CI 0.71-0.98). There were no differences between the two groups for neonatal outcomes of hypoglycemia, HIE and jaundice. CONCLUSION: The maternal and neonatal outcomes following birth are associated with the timing and management prior to delivery. These findings can be used to counsel women regarding the risks of maternal and neonatal complications from elective induction of labor and expectant management for one additional week. OBJECTIVE: Pregnant women often complain of fatigue but this is generally thought to be part of pregnancy due to hormonal changes. In the non-pregnant population obstructive sleep apnea (OSA) is a known contributor to fatigue but this has not been investigated in pregnant women. We therefore examined whether underlying OSA plays a role in fatigue during pregnancy. STUDY DESIGN: A secondary analysis of home sleep tests conducted among pregnant women for research purposes. All women were queried about symptoms of fatigue and daytime sleepiness using a fatigue scale and the Epworth Sleepiness Scale respectively. Women who reported that they experienced fatigue "often" were classified as cases. Excessive daytime sleepiness was considered present with a sleepiness score of !10. The presence of OSA was determined by an overnight home sleep test with an apnea-hypopnea index of !5 events/hour. Demographics and medical information was obtained by chart abstraction. Regression analyses were constructed to determine key contributors to fatigue. RESULTS: The sample size included 84 pregnant women (mean age 31.3AE5.9 years, and mean gestational age 29.0AE7.6 weeks). Thirtysix percent of women reported that they were "often" fatigued, 46% screened positive for daytime sleepiness, and 42% had OSA. Demographics are shown in Table 1 . There was no association between fatigue and daytime sleepiness. In a logistic regression model, a complaint of fatigue was strongly associated with the presence of OSA (OR 5.1, 3) after controlling for maternal age, gestational age, parity, BMI, race, and daytime sleepiness. CONCLUSION: Unrecognized OSA is a significant contributor to fatigue in pregnancy. Clinicians caring for pregnant women should consider OSA in women who are often fatigued. OBJECTIVE: Obesity has emerged as a leading cause of morbidity in reproductive aged women. It is associated with multiple maternal and fetal co-morbidities including pre-eclampsia, gestational diabetes and fetal growth restriction. It is also associated with obstructive sleep apnea (OSA), a treatable condition that is independently associated with gestational hypertension, pre-eclampsia, gestational diabetes, and fetal growth restriction. Despite the known association between obesity and OSA, pregnant women are rarely screened for OSA. Identification of high-risk women should be a priority in pregnancy as OSA can be treated. Thus, we investigated the relationship between the severity of obesity and the odds of objectively-assessed OSA. STUDY DESIGN: A secondary analysis of home sleep tests, conducted for research purposes between 2011-2018, in snoring and nonsnoring pregnant women was conducted. Body mass index (BMI; kg/m 2 ) was classified as normal weight (<25; referent) overweight
